Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Clinical trials of stem cell-based therapies for pediatric diseases: a comprehensive analysis of trials registered on ClinicalTrials.gov and the ICTRP portal site

Fig. 5

Distributions of origin, source organ, cell type, route of administration, specific product mentioned, and combination therapy of cell therapy. A Distribution of origins (autologous and allogeneic). B Distribution of source organs (BM, PB, UCB, UC, NT, AD, combination and other). C Distribution of cell types (NSCs, MSCs, HSCs, other and combination). D Distribution of administration routes (IC, IT1, IT2, IV, IA, IM1, IM2, IN, and combination). E Distribution of specific product names mentioned. F Distribution of combination therapy. BM: bone marrow, PB: peripheral blood, UCB: umbilical cord blood, UC: umbilical cord, NT: neural tissue, AD: adipose tissue, NSCs: neural stem cells, MSCs: mesenchymal stem cells, HSCs: hematopoietic stem cells, NA: not available, IC: intracranial, IT1: intrathecal, IT2: intratracheal, IV: intravenous, IA: intraarterial, IM1: intramyocardial, IM2: intramuscular, IN: intranasal

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512